story of the week
Effectiveness of Benralizumab in Patients With Severe Eosinophilic Asthma According to Previous Biologic Use and Key Clinical Subgroups
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The European Respiratory Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme
Eur. Respir. J. 2024 Jul 11;64(1)2301521, DJ Jackson, G Pelaia, B Emmanuel, TN Tran, D Cohen, VH Shih, A Shavit, D Arbetter, R Katial, APJ Rabe, E Garcia Gil, M Pardal, J Nuevo, M Watt, S Boarino, S Kayaniyil, C Chaves Loureiro, A Padilla-Galo, P NairFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.